Launch Sequence Aphrodisia Capsules recalled over undeclared tadalafil
- Recall date
- June 27, 2022
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Loud Muscle Science recalls Launch Sequence Aphrodisia Capsules, 4-count tins, ASIN B07QB3S2LV, UPC Code 661020846957.
- Recall number
- D-1338-2022
- FDA classification
- Class I
- Brand / firm
- Loud Muscle Science
- Sold / distributed
- The product was distributed nationwide in the USA and Canada.
Why it was recalled
Marketed Without An Approved NDA/ANDA: Product found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.
Class I is the FDA’s most serious recall level: there is a reasonable probability that using this product will cause serious harm or death.
What was recalled
Launch Sequence Aphrodisia Capsules, 4-count tins, ASIN B07QB3S2LV, UPC Code 661020846957.
Get recall alerts
Free email alert whenever Loud Muscle Science has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Loud Muscle Science